Showing results (241-250 of 257) with videos related to

Sort By:
Pageof 26
Elife|April 30, 2024
Germline <i>cis</i> variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (<i>DPYD</i>)Ting Zhang, Alisa Ambrodji, Huixing Huang, et al.
Equine Veterinary Journal|March 19, 2020
Plasma metabolomic profiling of healthy pregnant mares and mares with experimentally induced placentitisTheresa M Beachler, Hanna S Gracz, David R Morgan, et al.
Journal of Computer-Aided Molecular Design|January 25, 2020
D3R grand challenge 4: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energiesConor D Parks, Zied Gaieb, Michael Chiu, et al.
Journal of Medicinal Chemistry|July 1, 2008
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activityCheryl A Grice, Kevin L Tays, Brad M Savall, et al.
Development (Cambridge, England)|December 7, 2019
Aurora B functions at the apical surface after specialized cytokinesis during morphogenesis in <i>C. elegans</i>Xiaofei Bai, Michael Melesse, Christopher G Sorensen Turpin, et al.
Journal of Medicinal Chemistry|April 30, 2019
Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual InhibitorsHong Jia, Guangxiu Dai, Weiguo Su, et al.
Zentralblatt Fur Chirurgie|August 19, 2009
[Diagnosis of and therapy for gastric cancer--work-flow]R T Grundmann, A H Hölscher, A Bembenek, et al.
Molecular Pharmacology|March 5, 2011
Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitorTerrance D Barrett, Heather L Palomino, Theresa I Brondstetter, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 1, 2024
Age-Related Brain Atrophy and the Positive Effects of Behavioral Enrichment in Middle-Aged BeaglesJessica A Noche, Hamsanandini Radhakrishnan, Margo F Ubele, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin SecretagoguesMark D Rosen, Hariharan Venkatesan, Hillary M Peltier, et al.
Pageof 26